The Office of Graduate Studies is excited to invite graduate students to participate in our third annual Graduate Research Showcase! As part of our mission, the Office of Graduate Studies is driven to ...

Upon abstract acceptance, all posters must be uploaded and recorded on VoiceThread by January 26, 2026 at 5 p.m. All posters that are narrated on VoiceThread by the deadline will be officially listed ...

CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American ...

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...

Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional metabolic and fibrotic pathways in conditions resulting from the overproduction ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

For the selected target, LabGenius has developed a selectivity-enhanced TCE. The company’s lead optimisation platform, EVA™, was used to discover and concomitantly optimise a TCE with improved killing ...

MILAN (AP) — The Milan-Cortina 2026 Olympic organizing committee on Wednesday unveiled two official posters for the Winter Olympic and Paralympic Games — bold graphic depictions that officials said ...

DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP1R/GCGR dual agonist for the treatment of obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH) that is to be ...

Cyclin D1 is overexpressed in certain solid tumors and hematologic malignancies. In these cancers, the cyclin D1/CDK4 complex drives cell proliferation by binding to the tumor suppressor ...

DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment ...